Unknown

Dataset Information

0

Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.

ABSTRACT:

SUBMITTER: Speer C 

PROVIDER: S-EPMC8274271 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
| S-EPMC9045126 | biostudies-literature
Unknown BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents.
| S-EPMC8511403 | biostudies-literature
Unknown Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
| S-EPMC8063887 | biostudies-literature
Unknown Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis.
| S-EPMC8132255 | biostudies-literature
Unknown Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients.
| S-EPMC8695512 | biostudies-literature
Unknown Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
| S-EPMC8682749 | biostudies-literature
Unknown Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
| S-EPMC7612125 | biostudies-literature
Unknown Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
| S-EPMC8326656 | biostudies-literature
Unknown BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response.
| S-EPMC8058049 | biostudies-literature
Unknown Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naive and COVID-19-Convalescent Individuals.
| S-EPMC8500154 | biostudies-literature